Innovative biomimetic microfluidic technology licensed to RheoMeditech to enable new diagnostics for antiplatelet therapeutic window for cardiovascular patients.

Media coverage

• Title	Innovative biomimetic microfluidic technology licensed to RheoMeditech to enable new diagnostics for antiplatelet therapeutic window for cardiovascular patients.
  Media name/outlet	Get News.info
  Country/Territory	United States
  Date	22/7/7
  URL	https://www.getnews.info/1239343/innovative-biomimetic-microfluidic-technology-licensed-to-rheomeditech-to-enable-new-diagnostics-for-antiplatelet-therapeutic-window-for-cardiovascular-patients.html
  Persons	Sehyun Shin

• Title	Innovative biomimetic microfluidic technology licensed to RheoMeditech to enable new diagnostics for antiplatelet therapeutic window for cardiovascular patients.
  Media name/outlet	Austin-Online.com
  Country/Territory	United States
  Date	22/7/7
  URL	news.austin-online.com/story/372052/innovative-biomimetic-microfluidic-technology-licensed-to-rheomeditech-to-enable-new-diagnostics-for-antiplatelet-therapeutic-window-for-cardiovascular-patients.html
  Persons	Sehyun Shin

• Title	Innovative biomimetic microfluidic technology licensed to RheoMeditech to enable new diagnostics for antiplatelet therapeutic window for cardiovascular patients.
  Media name/outlet	HTV 10 - KFOL
  Country/Territory	United States
  Date	22/7/7
  URL	www.htv10.tv/story/46834980/innovative-biomimetic-microfluidic-technology-licensed-to-rheomeditech-to-enable-new-diagnostics-for-antiplatelet-therapeutic-window-for
  Persons	Sehyun Shin